Home > Insider Trading > Filing (0001209191-15-072592)

Filing Details

Accession Number:: 0001209191-15-072592
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-09-30 17:58:22
Reporting Period:: 2015-09-30

Filing Date:: 2015-09-30
Accepted Time:: 2015-09-30 17:58:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
815065	Steris Corp	STE	Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)	341482024

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1413087	Jr M Walter Rosebrough	C/O 5960 Heisley Road Mentor OH 44060	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares, No Par Value	Disposition	2015-09-30	5,000	$64.92	116,376	No	4	S	Direct
Common Shares, No Par Value	Disposition	2015-09-30	5,000	$64.93	20,000	No	4	S	Indirect	See Footnote Below.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Indirect	See Footnote Below.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Shares, No Par Value	98,040	Indirect	See Footnote Below.
Common Shares, No Par Value	6,960	Indirect	See Footnote Below.

Footnotes

This transaction involved the open market sale on September 30, 2015 of a total of 5,000 shares, held by the Reporting Person as Trustee, from his revocable trust established for his benefit, pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, as Trustee, on December 5, 2014.
This represents the average sales price of the 5,000 shares sold in the open market. The actual 37 sales prices ranged from $64.3300 per share to $65.3200 per share. Issuer, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of these 37 sales prices.
These 116,376 Common Shares are held by the Reporting Person as Trustee of a revocable trust established for his benefit. 44,750 of these Common Shares are restricted. The restrictions on the restricted Common Shares lapse as follows: 5,000 on May 31, 2016; 6,250 on May 31, 2016; 6,250 on May 31, 2017; 4,250 on May 30, 2016; 4,250 on May 30, 2017, 4,250 on May 30, 2018, 3,625 on May 30, 2016, 3,625 on May 29, 2017, 3,625 on May 28, 2018, and 3,625 on May 28, 2019.
This transaction involved the open market sale on September 30, 2015 of a total of 5,000 shares, held by the Reporting Person as Trustee, from an irrevocable trust established for the benefit of the children of the Reporting Person and the Reporting Person's Spouse, pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person, as Trustee, on December 4, 2014.
This represents the average sales price of the 5,000 shares sold in the open market. The actual 34 sales prices ranged from $64.2600 per share to $65.3200 per share. Issuer, upon request by the SEC staff, will provide full information regarding the number of shares sold at each of these 34 sales prices.
These shares are held by the Reporting Person as Trustee of an irrevocable trust established for the benefit of the children of the Reporting Person and the Reporting Person's Spouse.
These shares are held by the Reporting Person's Spouse as Trustee of a revocable trust established for her benefit.
These shares are held by the Reporting Person as Trustee of an irrevocable trust established for the benefit of the grandchildren of the Reporting Person and the Reporting Person's Spouse.